Insights

Strategic Recent Acquisitions Actylis has been actively expanding its product portfolio and manufacturing capabilities through recent acquisitions such as Pharm Rxchem and the sale of legacy manufacturing assets to Agno Pharma, indicating a strategic focus on enhancing its presence in the life sciences and API markets.

Industry Collaborations Partnerships like the one with United States Pharmacopeia and Emissarycosmetics demonstrate Actylis’s commitment to innovation and regulatory alignment, creating opportunities to collaborate on advanced formulations and compliance solutions.

Product Development Focus The launch of Water for Injection and new ISO Class 7 manufacturing space showcases their ongoing investment in high-quality, compliant biopharmaceutical ingredients, appealing to pharmaceutical clients seeking reliable and scalable manufacturing partners.

Market Expansion and Visibility Recent media coverage and executive leadership changes, including hiring a new CEO, suggest that Actylis aims to strengthen its market positioning and attract new clients through enhanced strategic leadership and heightened industry presence.

Financial Opportunity With estimated revenues between 10M and 25M and a focus on specialty ingredients and critical raw materials, Actylis offers growth potential for companies seeking reliable suppliers within the rapidly expanding life sciences and specialty chemicals sectors.

Similar companies to Biotron Laboratories, Inc. (now Actylis)

Biotron Laboratories, Inc. (now Actylis) Tech Stack

Biotron Laboratories, Inc. (now Actylis) uses 8 technology products and services including jQuery CDN, jsDelivr, BootstrapCDN, and more. Explore Biotron Laboratories, Inc. (now Actylis)'s tech stack below.

  • jQuery CDN
    Content Delivery Network
  • jsDelivr
    Content Delivery Network
  • BootstrapCDN
    Content Delivery Network
  • Cloudflare
    Content Management System
  • Salesforce
    Customer Relationship Management
  • TeamViewer
    Customer Service
  • Artifactory
    Development
  • Microsoft 365
    Email

Media & News

Biotron Laboratories, Inc. (now Actylis)'s Email Address Formats

Biotron Laboratories, Inc. (now Actylis) uses at least 2 format(s):
Biotron Laboratories, Inc. (now Actylis) Email FormatsExamplePercentage
First@biotronlabs.comJohn@biotronlabs.com
100%
FLast@actylis.comJDoe@actylis.com
100%

Frequently Asked Questions

Where is Biotron Laboratories, Inc. (now Actylis)'s headquarters located?

Minus sign iconPlus sign icon
Biotron Laboratories, Inc. (now Actylis)'s main headquarters is located at 750 North 120 West Centerville, Utah 84014 United States. The company has employees across 1 continents, including North America.

What is Biotron Laboratories, Inc. (now Actylis)'s phone number?

Minus sign iconPlus sign icon
You can contact Biotron Laboratories, Inc. (now Actylis)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Biotron Laboratories, Inc. (now Actylis)'s official website and social media links?

Minus sign iconPlus sign icon
Biotron Laboratories, Inc. (now Actylis)'s official website is actylis.com and has social profiles on LinkedIn.

What is Biotron Laboratories, Inc. (now Actylis)'s SIC code NAICS code?

Minus sign iconPlus sign icon
Biotron Laboratories, Inc. (now Actylis)'s SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 325 - Chemical Manufacturing.

How many employees does Biotron Laboratories, Inc. (now Actylis) have currently?

Minus sign iconPlus sign icon
As of March 2026, Biotron Laboratories, Inc. (now Actylis) has approximately 17 employees across 1 continents, including North America. Key team members include Chief Information Officer: F. G.Vice President Administrative Services: K. F.President: G. F.. Explore Biotron Laboratories, Inc. (now Actylis)'s employee directory with LeadIQ.

What industry does Biotron Laboratories, Inc. (now Actylis) belong to?

Minus sign iconPlus sign icon
Biotron Laboratories, Inc. (now Actylis) operates in the Chemical Manufacturing industry.

What technology does Biotron Laboratories, Inc. (now Actylis) use?

Minus sign iconPlus sign icon
Biotron Laboratories, Inc. (now Actylis)'s tech stack includes jQuery CDNjsDelivrBootstrapCDNCloudflareSalesforceTeamViewerArtifactoryMicrosoft 365.

What is Biotron Laboratories, Inc. (now Actylis)'s email format?

Minus sign iconPlus sign icon
Biotron Laboratories, Inc. (now Actylis)'s email format typically follows the pattern of First@biotronlabs.com. Find more Biotron Laboratories, Inc. (now Actylis) email formats with LeadIQ.

When was Biotron Laboratories, Inc. (now Actylis) founded?

Minus sign iconPlus sign icon
Biotron Laboratories, Inc. (now Actylis) was founded in 1979.

Biotron Laboratories, Inc. (now Actylis)

Chemical ManufacturingUtah, United States11-50 Employees

Actylis was created from the merger of eight experienced specialty manufacturing companies and three sourcing firms, integrated into a single entity.
Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and AgriScience industries.
Actylis' Nutrition division specializes in manufacturing mineral amino acid chelates and complexes. Our goal is to provide our corporate customers top-tier service and continual product improvement resulting in premium materials. To accomplish these goals, we rely on a depth of experience, a rigorous approach to product quality and emphasize both scientific validation and integrity.

Section iconCompany Overview

Headquarters
750 North 120 West Centerville, Utah 84014 United States
Phone number
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
NAICS Code
325 - Chemical Manufacturing
Founded
1979
Employees
11-50

Section iconFunding & Financials

  • $10M$25M

    Biotron Laboratories, Inc. (now Actylis)'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Biotron Laboratories, Inc. (now Actylis)'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.